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Abstract 
Honey bees, Apis mellifera, are markedly less sensitive to neonicotinoid insecticides 
containing a cyanoimino pharmacophore than to those with a nitroimino group. Although 
previous work has suggested this results from enhanced metabolism of the former by 
detoxification enzymes, the specific enzyme(s) involved remain to be characterised. In this 
work, a pre-treatment of honey bees with a sub-lethal dose of thiacloprid resulted in induced 
insensitivity to the same compound immediately following thiacloprid feeding. A longer pre-
treatment time resulted in no, or increased, sensitivity. Transcriptome profiling, using 
microarrays, identified a number of genes encoding detoxification enzymes that were 
overexpressed significantly in insecticide-treated bees compared to untreated controls. 
These included five P450s, CYP6BE1, CYP305D1, CYP6AS5, CYP315A1, CYP301A1, and 
an esterase CCE8. Four of these P450s were functionally expressed in E. coli and their 
ability to metabolise thiacloprid examined by LC-MS analysis. 
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1. INTRODUCTION 
Neonicotinoid insecticides are selective agonists of the invertebrate nicotinic acetylcholine 
receptor (nAChR), resulting in persistent excitation and ultimately death of the exposed pest 
insect (Jeschke and Nauen, 2008). Due to their excellent efficacy in crop protection, high 
specificity for insects and versatility in application methods they have become the market-
leading class of synthetic insecticides (Jeschke et al 2011). There have been concerns, 
however, on the possible effects of neonicotinoids on non-target organisms, especially insect 
pollinators such as honey bees (Goulson et al 2013).  Seed treatment and soil applications 
have tended to be the preferred application route for neonicotinioids as they protect young 
plants due to a long-lasting systemic effect, negating the need for foliar spray (Elbert et al., 
2008). Non-target arthropods such as  bees may be exposed to sublethal doses of these 
insecticides through both contact and oral routes when they visit plants during foraging 
activity and consume the affected food source (nectar and pollen) (Krupke et al., 2012; 
Blacquière et al 2012). The question of whether the sublethal doses, received by pollinators 
in the field, leads to significant impairment in individual and colony performance is a topic of 
active research and considerable controversy (for a review see Godfray et al. 2014). 
Cyano-substituted neonicotinoids (thiacloprid and acetamiprid) have been shown to 
be orders of magnitude less acutely toxic to honey bees than nitro-substituted compounds 
(imidacloprid, clothianidin, thiamethoxam, dinotefuran, nitenpyram) (Iwasa et al., 2004) and 
bioassays using inhibitors of detoxification enzymes have provided a strong indication that 
the differential toxicity observed between the two groups of neonicotinoids is due to 
increased metabolism of cyano-substituted compounds, rather than intrinsic differences in 
their affinity for the nAChR (Iwasa et al., 2004). The use of synergists has not, however, 
provided unequivocal evidence as to the primary enzyme system involved in the enhanced 
metabolism. It is perhaps more likely to be mediated by cytochrome P450s as pretreatment 
of honey bees with piperonyl butoxide (inhibitor of P450s and esterases) and other 
chemically distinct P450 inhibitors was shown to dramatically increase the toxicity of 
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thiacloprid and acetamiprid, whereas no significant differences were observed between 
bioassays with imidacloprid alone and those pretreated with these inhibitors (Iwasa et al., 
2004).  
It is well known that neonicotinoids can be metabolised by insecticide-resistant insect 
pests as a result of enhanced expression of specific cytochrome P450s, for example, 
CYP6CY3 in Myzus persicae and CYP6CM1 in Bemisia tabaci (Bass et al 2013, Karunker et 
al 2008).  Although honey bees have a relatively low number of CYP genes (46) encoding 
P450s compared to other insect species (Claudianos et al 2006), Hardstone et al. concluded 
“ (honey bees)..are not a highly sensitive species to insecticides overall, or even to specific 
classes of insecticides”  (Hardstone et al 2010). The precise P450s involved in the 
metabolism of cyano-substituted neonicotinoids in honey bees and whether their expression 
is constitutive or induced on exposure to neonicotinoids is unknown. However, P450 
induction by xenobiotics including non-neonicotinoid insecticides has been studied 
previously. Phenobarbital, a well-known general P450 inducer chemical, failed to induce the 
expression of any CYP genes in a microarray analysis of honey bees (Johnson et al., 2012). 
In contrast, Kezić et al. (1992) reported that benzo(a)pyrene monooxidase activity was 
induced after exposure of honey bees to benzo-(a)-pyrene (an inducer of human P450 
CYP1A1), the pyrethroid insecticide tau-fluvalinate and the miticide cymiazole. More recently 
in vitro characterisation of eight honey bee P450s of the CYP3 clan revealed that three 
members of the CYP9Q family have the capacity to metabolise the insecticides tau-
fluvalinate and coumaphos. Furthermore, the expression of the P450 CYP9Q3 was induced 
approximately 1.5-fold by tau-fluvalinate and CYP9Q2 by >1.5-fold by bifenthrin (Mao et al., 
2011). These findings demonstrate that using xenobiotics, particularly insecticides, as 
inducing factors might increase metabolic activity and allow identification of specific 
metabolic enzymes from honey bee that are involved in chemical defence. 
 The aims of this study were to use an induction strategy, in combination with a range 
of biological, biochemical and genomic approaches to determine 1) Do honey bees have the 
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ability to mount a molecular defence (via gene induction) to a neonicotinoid (thiacloprid) after 
initial exposure to a sub-lethal dose that results in a measurable alteration in phenotype to 
subsequent exposure? 2) What are the specific detoxification genes, particularly members of 
the P450 superfamily, induced by exposure to a neonicotinoid (thiacloprid) and 3) Do the 
enzymes induced have the capacity to metabolise the neonicotinoids and explain the 
differential toxicity of different members of the class?  
 
 
2 RESULTS 
2.1 Toxicity Bioassays 
Full-dose mortality response curves for the oral and contact toxicity bioassays with 
thiacloprid (Table 1) gave an estimated dose for induction (oral LD5) of 10 µg/bee and a 
dose for contact toxicity (LD50) of 61 µg/bee. For the oral toxicity assays the LD5 was 
estimated by assuming average consumption (0.055 mg/ml active). 
2.2 Induction Experiment 
Bee mortality differed between treatments applied topically  (acetone or thiacloprid; F1,52 = 
157.73, P < 0.001) and in the timing of topical application following oral pretreatment ( F3,52 = 
3.45, P = 0.023). There was also an interaction between oral treatment (thiacloprid or 
acetone) and time (F3,52 = 4.35, P = 0.008). Immediately following a pre-treatment time of 24 
h, topical application of thiacloprid resulted in increased tolerance compared to the controls 
(t-test, P = 0.006). At 48 h and 144 h there were no differences between thiacloprid or 
acetone pretreatment (t-test, P > 0.05). At 96 h there was a significantly increased sensitivity 
in the bees pre-treated with thiacloprid (t-test, P = 0.043). There was no significant difference 
in mortality in bees topically applied with acetone, regardless of whether oral pretreatment 
was thiacloprid or acetone (see Table 2 , Figure 1). 
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2.3 Transcriptome Profiling 
Transcriptome profiling using microarrays was used to compare gene expression in bees fed 
sucrose-insecticide (treated) and those fed sucrose syrup (control) at each time point. An 
additional array comparison was conducted comprising bees fed sucrose-insecticide that 
subsequently survived the 0 h topical bioassay versus the non-treated control from the same 
time point (‘survivor’ experiment). In the time course experiment 21 probes (11 upregulated 
and 10 downregulated), 39 probes (21 upregulated and 18 downregulated), 25 probes (18 
upregulated and 7 downregulated) and 13 probes (7 upregulated and 6 downregulated) 
were identified as encoding sequences significantly differentially expressed between control 
and treated bees at the 0 h, 48 h, 96 h and 144 h time points respectively. In the ‘survivor’ 
experiment 95 probes were identified as differentially expressed (57 probes were 
upregulated and 38 downregulated) between treated bees surviving the topical bioassay at 0 
h and non-treated controls from the same time point. The full lists of these probes, the genes 
to which they correspond and the calculated fold-change is in supplementary table 1. Gene 
enrichment analysis based on gene ontology revealed the enrichment of a number of GO-
terms in the differentially expressed gene sets of each time point (see Supp figures 1-5) with 
terms related to stress response (‘innate immune response’, ‘defense response to 
bacterium’, ‘response to oxidative stress’, ‘antioxidant activity’), a common theme observed 
between the time points. A greater number of GO-terms were enriched in the ‘survivor’ 
experiment, (Supp figure 5), with several terms suggestive of enhanced oxidative/P450 
activity including ‘oxidoreductase activity’, ‘oxidation-reduction process’, ‘heme binding’ and 
‘monooxygenase activity’. 
Among the differentially expressed probes were several corresponding to genes with 
putative roles in insecticide metabolism that are potential candidates to explain the 
alterations seen in phenotype in treated bees compared to controls. Thus in the 0 h 
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comparison two probes representing the P450 gene CYP315A1 were overexpressed (~1.5-
fold) and in the 48 h comparison a single probe for the gene cytochrome b5 was 
overexpressed 4.5-fold. At the 96 h time point three probes corresponding to the P450 gene 
CYP9Q1 and a single probe representing the carboxylesterase gene CCE11 were 
differentially expressed, however in all cases these were down regulated (-1.5 to -1.7). At the 
144 h time point no probes encoding detoxification enzymes were differentially expressed. 
The ‘survivor comparison’ displayed the greatest number of up-regulated probes encoding 
detoxification genes. This included four P450 genes, four probes for CYP6BE1 (1.9-2.2-fold), 
four probes for CYP305D1 (1.8-1.9-fold), four probes for CYP6AS5 (1.6-1.7-fold) and a 
single probe encoding CYP301A1 (1.6-fold). For esterases five probes encoding CCE8 were 
up-regulated 2.1-2.2-fold and for glutathione-s-transferases a single probe encoding GSTD1 
was over-expressed 1.9-fold. Finally a single probe representing the gene cytochrome b5 
was overexpressed (1.5-fold). 
A number of probes encoding genes associated with the regulation of 
transcription/signal transduction, which might be involved in the observed induction, were 
differentially expressed in multiple array comparisons. This included three G-protein-coupled 
receptor genes (GPCRs) in the survivor comparison (GB18244-RA, GB18304-RA and 
GB17560-RA), one GPCR related-gene (GB15369-RA) in the 0 h time point and one GPCR 
in the 144 h time point (GB18786-RA). Two genes encoding transcription factors (GB15791-
RA and GB10501-RA) were identified as differentially expressed in the 0 h time point, one in 
the 48 h time point (GB14951-RA), and two in the 96 h time point (GB18833-RA, GB12301-
RA). 
The expression levels of seven of the detoxification candidate genes from the 
microarray experiment were validated by qPCR with excellent concordance between fold-
changes calculated using the qPCR and array data (see Figure 2). The qPCR experiments 
provided confirmation that six of the seven candidate genes were significantly up-regulated 
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in treated bees compared to controls with the exception being GSTD1 which was eliminated 
as a potential candidate.  
 
2.4 Heterologous Expression of Candidate Genes 
For the genes (CYP305D1, CYP315A1, CYP6AS5, CYP6BE1 and cytochrome b5) 
confirmed as being up-regulated by qPCR, heterologous expression focused on exploring 
the functional role of the P450s in insecticide detoxification. In order to produce catalytically 
active P450s the candidate genes were co-expressed with an A. gambiae CPR in E. coli as 
previously described (McLaughlin et al., 2008). Variation was observed in the yield of 
recombinant P450 (Table 3), however, reduced CO-difference spectra suggested correctly 
folded and active enzyme as indicated by significant peaks at 450 nm and lesser 420 nm 
peaks (Supp Figure 6). The cytochrome b5 was also successfully expressed and purified 
from E. coli membranes. 
 
2.5 Metabolism Assays 
The ability of CYP305D1, CYP315A1, CYP6AS5 and CYP6BE1 proteins (in combination 
with the A. gambiae CPR and bee cytochrome b5) to detoxify thiacloprid and imidacloprid in 
the presence and absence of NADPH was examined in insecticide metabolism assays. 
Figures 3 and 4 outline the results of monitoring thiacloprid and imidacloprid recovery in the 
samples using srm methods, with quantification against standard calibration curves. No 
significant differences were observed in thiacloprid or imidacloprid recoveries between the 
+/- NADPH samples for any of the four P450s.  
 
3. DISCUSSION 
Honey bees display profound differences in their susceptibility to different neonicotionoid 
insecticides, being considerably less sensitive to cyano-substituted neonicotinoids such as 
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thiacloprid. Research to date has provided strong indications that this is due to an innate 
ability of the bees to metabolise neonicotinoids containing a cyano pharmacophore; 
however, the precise metabolic enzymes involved and whether their expression is 
constitutive or induced upon exposure to neonicotinoids was unknown. The main aim of the 
present study was to address these two questions by feeding bees a sublethal dose of 
thiacloprid and assessing 1) changes in thiacloprid sensitivity in bioassays and 2) changes in 
gene expression in whole transcriptome microarrays. 
 The bioassay time course experiment showed that a measurable reduction in 
thiacloprid sensitivity could be induced in honey bees after exposure to a sub-lethal dose of 
this neonicotinoid for 24 hours. This effect was time dependent with increased tolerance only 
observed immediately following the 24 h of thiacloprid feeding, with treated bees becoming 
more susceptible than controls at the later time point (96 h). To our knowledge this is the first 
report with honey bees of a sub-lethal dose of an insecticide providing a protective effect to 
subsequent exposure of the same insecticide. Indeed, in a related study on honey bees, no 
effect on the toxicity of the pyrethroid insecticide tau-fluvalinate was observed in bees fed 
phenobarbital, xanthotoxin, salicylic acid, indole-3-carbinol compared to controls fed 
sucrose, although  the effect of tau-fluvalinate feeding on subsequent tau-fluvalinate toxicity 
was not examined (Johnson et al 2012).  
One possible explanation for our finding of an induced decrease in sensitivity to 
thiacloprid in bees is that the sub-lethal exposure activates the transcription of one or more 
genes encoding detoxification/defence proteins over the 0-48h time points and that these 
subsequently return to constitutive levels or lower than constitutive levels at the later time 
points. To explore this we carried out a series of microarray comparisons of global gene 
expression levels in treated versus control bees over the time series (‘time course 
experiment’) and a second experiment where treated bees surviving the topical bioassay at 
0 h were compared with non-treated controls from the same time point (‘survivor 
experiment’). Across all comparisons the number of genes differentially expressed (13-96 
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probes representing 0.08-0.6% of the 15737 probes on the array), and the fold changes 
observed (<8-fold), between treated and control bees were low. Nevertheless, the observed 
changes were subsequently confirmed by qPCR with a number of candidate genes being 
validated as moderately, but significantly, over-expressed in treated bees. GO-term analysis 
of these differentially expressed genes revealed enriched ontology terms associated with a 
general stress response and also terms relating to P450-mediated detoxification, the latter 
resulting from the enhanced expression of a number of probes encoding several honey bee 
P450s/cytochrome b5. P450 genes were only identified in the earlier time points (0h, 0h 
survivors, 48h) where altered thiacloprid toxicity was observed in bioassays and the only 
gene related to detoxification observed in two separate array experiments was cytochrome 
b5, which can act as an electron donor to P450s. Among the CYP genes CYP315A1 was the 
only P450 identified as overexpressed in the time course experiment (at the 0 h time point) 
and this is the ortholog of the Drosophila melanogaster sad gene encoding the steroid 2-
hydroxylase (Claudianos et al 2006). However, in the ‘survivor’ experiment in which ‘treated 
bees’ were fed thiacloprid for 24 h and then survived a subsequent topical application of 
thiacloprid (LD50) a number of P450s were identified as being over-expressed. This included 
two members of the CYP3 clade CYP6BE1 and CYP6AS5, whose members have been 
most commonly involved in detoxification of xenobiotics including pesticides in other insects 
(Li et al 2007). Two further P450s CYP305D1 and CYP301A1, the latter of which was only 
represented by a single probe, belong to the CYP2 and mitochondrial clades respectively 
were also overexpressed. The role of CYP305D1 is yet to be determined but CYP301A1 is 
thought to be involved in ecdysone regulation during adult cuticle formation (Sztal et al 
2012). Beyond detoxification genes several genes involved in the regulation of 
transcription/signal transduction were also identified as differentially expressed in multiple 
array comparisons including both transcription factors and a number of G-protein-coupled 
receptors (GPCRs). It is possible that these genes may play a role in triggering/regulating 
the enhanced transcription of the CYP/detox genes. In the case of GPCRs recent work has 
suggested they may be involved in regulating overexpressed P450s observed in resistant 
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moquitoes, Culex quinquefasciatus, and housefly, Musca domestica, (Li et al 2014, Li et al 
2013). For C. quinquefasciatus knockdown of four GPCR genes by RNAi both decreased 
resistance to permethrin and repressed the expression of four insecticide-resistance related 
P450 genes (Li et al 2014). It would be interesting to examine the role of these receptors in 
honey bee gene expression responses to xenobiotics in more detail using a similar 
approach. 
The four P450s, CYP6BE1, CYP6AS5, CYP315A1 and CYP305D1, all of which were 
represented by multiple overexpressed probes in array comparisons and validated by qPCR, 
were functionally expressed in E.coli in combination with the A. gambiae P450 reductase to 
examine their potential to metabolise thiacloprid. Honey bee cytochrome b5 was also 
expressed and included in metabolism assays as this enzyme has been show to modify the 
catalytic activity of P450s in other insect systems. Although functional P450 proteins were 
obtained for all four CYP genes, no metabolism of thiacloprid (as assessed by parent 
compound depletion after incubation of thiacloprid with recombinant P450 in the presence of 
NADPH) was observed for any of the four P450s. These findings suggest that the P450s 
induced in our experiments do not have the ability to detoxify thiacloprid and if innate bee 
tolerance to this compound is indeed mediated by P450s, their expression may be 
constitutive and hence would not have been detected in our experiments. Alternatively a 
different enzyme system, such as esterases may be responsible for thiacloprid metabolism/ 
sequestration. Indeed, the toxicity of the nitro cyano-substituted neonicotinoid acetamiprid 
was synergised (synergism ration of 2.96) by the inhibitor S,S,S,-
tributylphosphphorotrithioate (DEF) suggesting esterases may play a contributory role in 
detoxification (Iwasa et al 2004). In our ‘survivor’ array comparison five probes representing 
the esterase CCE8 were overexpressed and this was confirmed by qPCR. This CCE falls 
into clade A, classified as intracellular enzymes with dietary/detoxification functions 
(Claudianos et al 2006). Attempts to functionally express this esterase resulted in non-
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functional enzyme (data not shown) so we were unable to confirm any role of this enzyme in 
thiacloprid metabolism. 
In summary a number of genes, including several P450s, are induced in honey bees 
exposed to a sub-lethal dose of thiacloprid and this is associated with a measurable, 
temporary, reduction in toxicity on subsequent thiacloprid exposure. However a causative 
role for these P450s in thiacloprid tolerance could not be demonstrated and the specific 
enzymes involved in the thiacloprid insensitivity remain to be determined. 
 
4 EXPERIMENTAL PROCEDURES 
4.1 Insect Material 
Apis mellifera carnica was provided by the AgroEcology Department, Rothamsted 
Research. All Rothamsted Research hives were treated with Fumidil (an antibiotic to treat 
Nosema disease) in September, and treated with Apiguard (to reduce Varroa mite) in August 
and September by the beekeeper. The colonies were checked weekly between April and 
September, given more boxes/space as required, honey taken off for extraction during the 
summer, and fed sugar syrup in the autumn to maintain the hive through winter. Frames of 
sealed brood were collected and incubated at 34°C overnight. Emerged worker bees were 
used for the bioassays.  
 
4.2 Reagents 
Restriction enzymes were supplied by Promega (UK); oligonucleotides, technical 
insecticides (PESTANAL) and other analytical grade reagents were obtained from Sigma-
Aldrich (UK).  
4.3 Toxicity Bioassays 
4.3.1 Oral toxicity tests 
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Technical grade thiacloprid was dissolved in acetone and then added to sucrose syrup 
(50%) in water. Newly emerged worker bees (~10) were transferred to plastic cages after 
anesthetising with CO2 where they were treated with a range of thiacloprid concentrations for 
24 h through oral feeding; the amount of treated diet consumed by each cage was measured 
by the difference in weight of sucrose syrup before and after the experiment. All treated bees 
were maintained at 25oC in the dark. All bioassays were scored after 24 h and bees not 
walking or flying were counted as dead. 
 4.3.2 Contact toxicity tests 
Samples were also subjected to a range of thiacloprid concentrations by topical application: 
newly emerged worker bees were transferred to plastic cages after anesthetising with CO2 
(ten bees per cage, at least three replicates per insecticide dosage). For each cage a 
reservoir of 50% sucrose in water was available for ad lib feeding. Prior to treatment bees 
were anesthetised by low exposure to CO2. Each bee was topically dosed (1uL) with either 
thiacloprid in acetone or acetone alone applied to the dorsal thorax using a Burkard 
microapplicator (Burkard, Rickmansworth, UK). All treated bees were maintained at 25oC in 
the dark and bioassays were scored after 24 h, bees not walking or flying were counted as 
dead.  
4.4 Induction Experiment 
Thiacloprid toxicity was assayed in vivo after exposure to a sub-lethal concentration of 
thiacloprid, to check for measurable alteration in phenotype. A factorial set of 16 treatments 
was tested in two repeat experiments. Bees (9–15 per cage = one replicate, 72 cages in 
total) were fed either a sub-lethal dose (LD5 0.055 mg/ml) of thiacloprid (dissolved in acetone 
and then sugar solution) or acetone in sugar solution (controls) for 24 h. At each time point, 
(0 h, 48 h, 96 h and 144 h) immediately prior to topical application, 2 cages of oral fed 
acetone and 2 cages oral fed thiacloprid were snap frozen for microarray analysis as 
described in section 4.5 (16 cages total for each of experiment 1 and 2); . At each of 0 h, 48 
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h, 96 h and 144 h a diagnostic dose of thiacloprid (61 µg equating to LD50) in acetone or 
acetone alone was then topically applied to at least 4 cages of oral fed acetone and oral fed 
thiacloprid to give at least 2 cages of each possible combination (acetone-acetone, acetone-
thiacloprid, thiacloprid-acetone, thiacloprid-thiacloprid) at least 32 cages total for each of 
experiment 1 and 2 (Figure 5). Samples of bees surviving the treatment (“survivors”) were 
snap frozen and stored at −80°C for subsequent molecular analyses as described in section 
4.5. 
 
4.5 Microarray Analysis 
A custom microarray designed using the Agilent eArray platform (Agilent Technologies) 
contained 60bp oligonucleotide probes for each of the honey bee consensus gene set 
(~10,000 genes) derived from the annotated honey bee genome. A SurePrint HD (8×15k) 
expression array was designed using the  base composition and the best probe 
methodologies to design sense orientation 60-mer probes with a 3′ bias. For each contig 
encoding a detoxification enzyme (P450s, GSTs and CEs) three probes were designed. 
Additional probe groups for 15 control genes were included.  
Groups of four bees per replicate were ground to a fine powder in liquid nitrogen 
using a pestle and mortar. RNA was extracted from the pooled homogenates using the 
Bioline Isolate RNA Mini Kit according to the product manual. The quantity of RNA was 
checked using a nanodrop spectrophotometer and by running an aliquot on a 1.5% agarose 
gel. For the latter, RNA was mixed with 1x loading buffer (95% formamide; 0.025% xylene 
cyanol; 0.025% bromophenol blue; 18 mM EDTA; 0.025% SDS), heated for 5 minutes at 65 
°C and briefly chilled on ice prior to loading. Two micrograms of each RNA was used to 
generate labelled cRNA, which was hybridised to the arrays, which were then washed and 
scanned as described in the Agilent Quick Amp Labeling Protocol (Version 5.7). The 
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experiments consisted of four/five biological replicates and for each of these, hybridisations 
were done in which the Cy3 and Cy5 labels were swapped between samples. 
Microarrays were scanned with an Agilent G2565CA scanner and fluorescence intensities of 
individual spots were obtained using the Agilent Feature Extraction software with default 
Agilent parameters.  Data normalization, filtering, dye flipping and statistical analysis were 
performed using the GeneSpring GX suite. For statistical analysis, a t-test with null 
hypothesis of no difference between treatments was used to detect differentially expressed 
genes. Genes were considered differentially expressed if they had a P value of <0.05 and a 
fold change (up or down) greater than 1.5. 
 
4.6 Quantitative PCR 
Primers were designed to amplify a fragment ~100 bp using the Primer3 program (Table 4). 
4 µg of RNA was used for reverse transcription using Superscript II Reverse Transcriptase 
and random hexamers (Invitrogen). Each PCR reaction consisted of 4 µl of cDNA (10 ng), 5 
µl of SensiMix SYBR Kit (Bioline) and 0.5 µl of each forward and reverse primer (0.25mM). 
PCRs were run on a Rotor-Gene 6000 (Corbett Research) with cycling conditions: 10 
minutes at 95°C followed by 40 cycles of 95°C for 15 s, 60 °C for 15 s and 72°C for 20 s. A 
final melt-curve step was included post-PCR (ramping from 72°C to 95°C by 1°C every 5 s) 
to confirm the absence of any non-specific amplification. The efficiency of PCR for each 
primer pair was assessed using a serial dilution from 100 ng to 0.01 ng of cDNA. Each qRT-
PCR experiment consisted of at least three independent biological replicates with two 
technical replicates. Data were analysed according to the ΔΔCT method (Pfaffl 2001), using 
the geometric mean of two selected housekeeping genes (elongation factor and actin) for 
normalisation according to the strategy described previously (Vandesompele et al. 2002). 
4.7 Heterologous Expression of Candidate Genes 
4.7.1 Cloning CYPs 
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The candidate honey bee P450s (CYP305D1, CYP315A1, CYP6AS5, CYP6BE1) were 
amplified from cDNA using KAPA high-fidelity DNA Polymerase (Kapa Biosystems) following 
the product manual. As a proofreading DNA polymerase was used for amplification, which 
leaves blunt ended DNA, A-tailing reactions were carried out prior to cloning. After the 
product was cleaned, it was ligated into the pSC-A-amp/kan cloning vector. For functional 
P450 expression in E. coli the N-terminal coding region of each P450 cDNA was modified: 
the ompA leader sequence (21 amino acid residues) and two linker amino acid residues 
(alanine-proline) were added to the 5' end of P450s (ompA+2 strategy) (Pritchard et al, 
1997; 2006, McLaughlin et al, 2008). This was achieved by two fusion PCR reactions, 
carried out using high-fidelity DNA polymerase according to the manufacturer’s instructions. 
In the first PCR, genomic DNA of the E. coli JM109 cell line was used as template to amplify 
a ~100 bp nucleotide fragment (containing the ompA+2 sequence and the first 21 bases of 
the target P450 gene) preceded by a NdeI restriction site using the primers described in 
Table 5. This intermediate PCR product was purified and then fused to the P450 plasmid 
template in a second PCR reaction using the same forward and CYP specific reverse 
primers (table 5) to generate the full-length ompA-AP-CYP coding sequence flanked by NdeI 
and XbaI restriction sites. The final product was digested and ligated into modified pCW-ori+ 
vector via XbaI and NdeI restriction sites and the final sequence were confirmed by 
sequencing prior to expression. 
4.7.2 Preparation of membranes 
Competent E. coli JM109 cells were co-transformed with pCW-Ori+CYPs and pACYC-
AgCPR to enable co-expression of each CYP with the Anopheles gambiae CPR following 
the methods described by Stevenson et al. (2012). Plasmids were transformed into JM109 
cells and overnight cultures in 200 mL terrific broth incubated at 30°C with shaking. When 
the cultures reached early log phase growth expression was induced by adding 1 mM IPTG. 
δ-aminolevulinic acid hydrochloride was added to a final concentration of 0.5 mM at the 
same time to compensate the low levels of endogenous heme in the bacterial cells. Further 
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incubation was at 24°C for 23 hours before the cells were harvested by centrifugation and 
membranes prepared as described by Pritchard et al. 1998. Membranes were resuspended 
in ice-cold 1X TSE buffer in a Dounce tissue homogeniser and aliquots stored at -80oC. 
P450 content (Omura and Sato, 1964), total protein concentration (Bradford, 1976) and CPR 
content (Strobel and Dignam, 1978) were analysed. 
4.7.3 Cloning cytochrome b5 
To simplify the purification of the expressed b5 protein the N-terminal coding region was 
modified by the addition of six histidine residues (6H) to the 5' end (Holmans et al., 1994; 
Stevenson et al., 2011). This was achieved using high-fidelity DNA polymerase and the 
forward primer 5'-
GGAATTCCATATGCACCATCACCATCACCACATGTCGAAAATTTTTACAGCGGA-3' 
(NdeI restriction site underlined and six histidine codons in bold before start codon) and 
reverse primer 5'-GAATTCTCTAGATTATGAATACCAAAAATAGTAAAAT-3' (XbaI restriction 
site underlined). The final product was digested and ligated into the modified pCW-ori+ 
vector via the XbaI and NdeI restriction sites with the final sequences confirmed by 
sequencing prior to expression. 
4.7.4 Expression and purification of cytochrome b5 
The 6H-b5 construct was transformed into JM109 cells and after overnight culture was 
transferred to 500 mL terrific broth (TB) media containing 50 µg/mL of ampicillin in a 1L flask 
and shaken at 37°C at 200 rpm and expression induced as described above. Cells were 
harvested as for the P450s. Pelleted cells were resuspended and treated by the Holmans et 
al. (1994) method with Stevenson et al. (2011) modifications. Expression of b5 was checked 
and quantified by spectrophotometry (Omura and Sato, 1964). 
4.8 Insecticide Metabolism  
Insecticide (thiacloprid and imidacloprid) metabolism assays of recombinant bee 
P450s/CPR/b5 standard reactions were carried out using three replicates for each P450 in 
the presence or absence of NADPH. A 10 mM stock solution of thiacloprid and imidacloprid 
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were prepared in DMSO and diluted to 100 µM in phosphate buffer (0.1 M, pH 7.6) before 
adding the reaction to avoid the precipitation of insecticide. Standard reactions consisted of 
final concentrations of 10 µM insecticide, 100 µl NADPH regeneration system (Promega) (or 
buffer alone in the case of minus NADPH controls), 0.0117 µM cytochrome b5 and 0.1- 0.4 
µM P450 membrane. Reactions (200 µl total) were incubated at 30⁰C, shaking at 1200 rpm 
for 2 h and then stopped by adding 300 µl of acetonitrile. Samples were then spun at 2000 g 
for 5 min and 250 µl of supernatant was transferred to HPLC vials and stored at -20⁰C for 
LC-MS/MS analysis. 
4.9 LC-MS Analysis 
Aliquots of each sample were diluted 50:50 in acetonitrile prior to LC-MS/MS analysis. 
Separation was achieved using Ultra Performance LC® (ACQUITY UPLC-System; Waters, 
UK) using an ACQUITY UPLC column (HSS T3, 1.8 μm, 100 x 2.1 mm), with a mobile phase 
consisting of water (+0.2% formic acid), with a flow rate of 0.6 mL/min. The gradient elution 
conditions of acetonitrile:water were: 0 min 0:100, 0.5 min 0:100, 3.5 min 95:5, 4.5 min 95:5, 
4.6 min 0:100, 5 min 0:100. The mass spectrometer was a Finnigan TSQ Quantum 
Discovery (Thermo Scientific, UK) equipped with an Ion Max source operating in positive ion 
mode. Analytes were detected using selected-reaction-monitoring (SRM), transitions as 
outlined in table 6. Quantification was achieved using standard calibration curves 
constructed in 50:50 acetonitrile:water.  
4.10 Statistical analysis 
Table 1 shows the results of probit analysis of the data from full dose oral and contact 
bioassays using the statistical program PC Polo Plus (LeOra Software, Berkeley, CA), and 
concentrations required to kill 5% of the population (LD5, oral) and 50% of the population 
(LD50, contact) were estimated after correcting for control mortality (Abbott 1925, Finney 
1971). Data from the induction bioassays were analysed in GenStat (14th edition, VSN 
International) using logistic regression (i.e. a generalized linear model with binomial error 
18 
 
and logit link), allowing for differences between experiments before testing treatment effects 
and with adjustment for over-dispersion. 
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Tables 
Table 1 
Full dose response bioassays of honey bee against thiacloprid (µg/bee) 
Bioassay LD05  LD50 CL 95% Slope ± SE df Χ
2
 No. 
Oral 10.1  4.45 – 16.2 2.29 ± 0.33 13 12.3 150 
Contact  61.3 41.0 – 85.2 2.05 ± 0.32 13 17.3 150 
 
LD05 = lethal dose of thiacloprid to kill 5% of the population. 
LD50 = lethal dose of thiacloprid to kill 50% of the population  
CL = Confidence limits; df = degrees of freedom; Χ
2 
= chi-square; No. = number of bees  
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Table 2 Comparison of mean mortalities (logit scale) for bees fed either thiacloprid or 
acetone and subsequently topically applied with either acetone or thiacloprid at 
various times post-feeding 
 
TIME 0 h 48 h 96 h 144 h 
Topical Ace Thia Ace Thia Ace Thia Ace Thia 
Difference 0.966 -1.351 0.471 -0.628 -0.419 0.978 0.766 0.789 
t-statistic 0.628 -2.884 0.384 -1.199 -0.403 2.075 0.470 1.547 
P value 0.533 -0.006 0.702 0.236 0.688 0.043 0.640 0.128 
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Table 3 P450 concentration and CPR activity in expressed CYPs 
CYPs P450 concentration 
(nmol P450/mg protein) 
CPR activity 
(nmoles cyt c/min/mg 
protein) 
CYP305D1 0.17 8.8 
CYP315A1 0.116 6.9 
CYP6AS5 0.045 4 
CYP6BE1 0.0518 7 
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Table 4 Oligonucleotide primer sequences used in qPCR 
 
Gene Accession 
no 
Primer Sequence (5ˈ- 3ˈ) Product 
size 
(bp) 
CYP305D1 GB11943 Forward GGACGTCCTTGGAACGAAT 108 
  Reverse TCGCATCATCCAATTTCGTA  
CYP315A1 GB16447 Forward CTGGGTCCCGTTTACAAAGA 101 
  Reverse GGTGTTGACCCTTCAAGTCG  
CYP6AS5 GB17434 Forward CAGGCTCTCCCCAATATTCA 120 
  Reverse TCGATGGGCTCATTTTTCTC  
CYP6BE1 GB14612 Forward CGAAAGGAACTTGCATAGCC 120 
  Reverse TCTTCGGAAAATCGTTCTGG  
Cytb5 GB12288 Forward CAGCGGAAGAAGTAGCGAAA 101 
  Reverse GCCTGGATGTTCGCTTAGAA  
GSTD1 GB18045 Forward AAAAATGCTTGTTATTTTCTGTCTGA 110 
  Reverse TCAAACGCGTCTTCGAGTATC  
CCE8 GB11064 Forward TCTGCTTGCGCATTCTATTG 106 
  Reverse CTTTACGCGCTTCTTTGTCC  
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Table 5 Primers used for fusion PCRs. All primers are listed in the 5' to 3' direction 
 
CYPsa Reverse Primerb CYP Specific Reverse Primerc 
ompA-AP-
CYP305D1 
ACTATTAACATTATAACAAACAT 
X 
GAATTCTCTAGATTATCGTTTTTCAA
CTAATACA 
ompA-AP-
CYP315A1 
AATATTTTGCGCAAGATTCAT X 
GAATTCTCTAGACTAATTTCTCTCCA
TCAATTT 
ompA-AP-
CYP6AS5 
AATTTCGAAACTGCTCGCCAT X 
GAATTCTCTAGATCATATTTTTGTTA
TTTTCAAATA 
ompA-AP-
CYP6BE1 
TAACCACGTAGTTAAAAACAT X 
GAATTCTCTAGATTATATTGGCTCAA
TATTTAGA 
aThe forward primer used for ompA+2 fusion PCR strategy was always 5'- 
GGAATTCCATATGAAAAAGACAGCTATCGCG -3' with the NdeI restriction site underlined. 
bReverse complement of the start of CYPs and X represents 5'- 
CGGAGCGGCCTGCGCTACGGTAGCGAA-3' which corresponds to the reverse 
complement of proline and alanine codons and the ompa segment sequence. 
cThe region corresponding to the reverse complement of the end of CYPs with XbaI 
restriction site (underlined). 
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Table 6: SRM transitions and collision energies 
Analyte 
Molecular 
Weight (Da) 
SRM Transition 
Parent m\z > Product m\z 
Retention Time (min) 
Thiacloprid 254 
253 > 126 
253 > 186 
4.83 
Imidacloprid 257 
256 > 175 
256 > 209 
4.47 
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Figures 
 
Figure 1 Treatment mean mortalities (logit scale; n = 1–3 cages of 9–15 bees) from 
logistic regression (± SE).  Fed acetone, topical acetone (circles); fed thiacloprid, 
topical acetone (diamonds); fed acetone, topical thiacloprid (squares); fed thiacloprid, 
topical thiacloprid (triangles). Time = delay following 24 h oral pre-treatment. Inner Y-
scale represents mortality (%). Mortality was assessed 24 h after topical application. 
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Figure 2 Expression levels determined with qPCR for selected genes using the 
geometric mean of a selected housekeeping genes (ef1 and actin) (error bars show 
95% confidence limits) 
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Figure 3 Recovery of thiacloprid after a 2 h incubation with the four honeybee P450s. 
Graph represents mean final recovery (μM) ± SE (n = 3) 
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Figure 4 Recoveries of imidacloprid after a 2 h incubation with the four honeybee 
P450 expression systems. Graph represents mean final recovery (μM) ± SE (n = 3) 
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Figure 5 Experimental design 
Honey bees were fed either thiacloprid at an estimated LD5 dosage or acetone (time -24 h to 
0 h). At times in circles (0, 48, 96, 144 hours after oral feeding finished) topical application 
(at estimated LD50 dosage or acetone) took place; concurrently, separate cages were taken 
for microarray analysis. Mortality assessment (scoring) took place 24 h after topical 
application and survivors were snap frozen.  
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Supplementary Table 1 Lists of differentially expressed probes in all microarray 
experiment, the genes to which they correspond, p values and the calculated fold-
changes are detailed. 
 
Supplementary Figures 1-5 Enriched Gene Ontology (GO) terms in genes differentially 
expressed in each microarray comparison. 
 
Supplementary Figure 6 Reduced CO-difference spectra of recombinant CYP6BE1, 
CYP6AS5, CYP315A1 and CYP305D1. 
